Picture of ACCUSTEM SCIENCES logo

ACUT ACCUSTEM SCIENCES Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for ACCUSTEM SCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.671-3.75-2.05-1.51-1.76
Depreciation
Non-Cash Items0.0210.0670.0790.3030.168
Other Non-Cash Items
Changes in Working Capital0.6491.870.3530.5340.738
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities0-1.81-1.62-0.664-0.85
Capital Expenditures-0.01100
Purchase of Fixed Assets
Cash from Investing Activities-0.01100
Financing Cash Flow Items0.2051.250.7810.957
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.550.9030.6480.859
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash00.734-0.713-0.0160.009